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BurkhoMeria cepacia complex (13 CC) organisms are a group of genomovar s which 
can cause morbidity and mortality in patients with cystic fibrosis (CF). Previous 
investigations have elucidated the presence of several B. cetu~cepacia (genomovar 
I l l )  strains which are responsible for a poorer prognosis amongst hese patients. 
A l though BCC infection in the non CF setting is usually in an immuno 
compromised host, nosocomial transmission has been reported. Methods:  A 
combination of PFGE & REP PCR was used to investigate he epidemiology of B. 
cetu~cepacia. Isolates used in the study represented a prospective collection of 116 
CF associated and 45 non CF organisms from 159 patients in Australia and New 
Zealand. Each isolates profile was compared to other organisms of the same species 
and a combination of epidemic and non epidemic BCC conlrol strains. Resulrs: 
Excluding B. cetu~cepacia, no relatedness was detected amongst the CF associated 
isolatesfromanyofthegenomovars. B. cenocepaciaisolates(n 53) includedin the 
study were divided into two distinct recA based lineages; A (n 18) and B (n 35). 
Of  the CF associated B. cetu~cepacia A isolates, no Northern hemisphere epidemic 
strains were detected. In contrast, 40% of the CF associated B. cetu~cepacia B 
isolates belonged to a cluster related to the Austral ian epidemic strain and were 
collected only from patients attending CF units in Queensland and NSW. 
Conclusion: Sixty two percent of the non CF associated isolates were collected 
from patients with cbronic lung disease or intensive care unit exposure. Only one 
instance revealed strain typing reveal the presence of an identical strain in more than 
one patient. 
Supported by the TPCH Fowulation. 
Infection with B cetu~cepacia arries a poor prognosis, partly due to a necrotising 
fulminant pneumonia (the cepacia syndrome) which is said to occur in 20% of cases 
and within the first few months of infection. We have noticed this yndrome 
occurring many years after initial infection ha our large cohort of B cenocepacia 
patients, and report our experience. 
38 patients have been cbronically infected (mean age 28.1 years [range 18 to 42], 
mean length of infection 73.6 months [1 to 128], 20 male), and 26 (68%) have died. 
Of  these, only 7 succumbed to respiratory fai lure caused by progressive lung 
damage (mean age 28.9 years [21 to 42], mean length of infection 57.3 months [10 
to 127], 4 male), and 19 (73%) to the cepacia syndrome (mean age 25.8 years [18 
to 26], mean length of colonization 60.7 months [1 to 128], 10 male). 
Only 5 died of cepacia syndrome within 6 months of initial infection and 4 had 
previously been infected by other genomovars (I, IIIa, IV, V). The remainder all 
survived more than 21 months, and in 9 the cepacia s3,ndr ome occuTred more than 
5 years post infection, ha 6 of these there appeared to be a physical intuit that 
precipitated the cepacia syndrome (1 pneumothorax, 1 severe viral gut infection, 1 
complicated arm fracture, 1 severe otitis media, 1 liver transplant and 1 liver 
failure). A l l  these individuals had pulmonary function >60% predicted and no 
l imitation of exercise tolerance. 
Thus, we have shown that cepacia syndrome frequently occurs as a late 
complication of B cetu~cepacia infection. Since the syndrome is invariably fatal, 
these deaths are causing anxiety hathe remaining cohort and such developments 
must be borne in mind in other units with large cohorts of B cenc~:epacia p tients. 
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Al l  genomovar s of the BurkhoMeria cepacia corr~Ie~ (BCC) are capable of causing 
infection in CF. Epidemiology of BCC and clinical outcomes are variable. Our aim 
was to define the occurrence of transient colonisation of BCC in an adult CF unit. 
Methods: Pulmonary function, microbiology and nutritional state were analysed 
from 32 CF patients two years prior to and fol lowing the isolation of BCC 1995 
2C~)3. rec A based PCR assays and 16S rDNA RFLP analysis was used to determine 
genomovar diversity of BCC. We compared persistent vs transient BCC (<3 BCC 
isolates in 2 years) and genomovar III with non genomovar III BCC isolates. 
Statistical analysis was performed on SPSS; Z 9 test for categorical data, t test and 
Mann Whitney U test for continuous data. Results: Prom 32 patients, 17.6% B 
cepacia (n 6), 17.6% B multivorans (n 6), 17.6% B cetu~cepacia A (n 6), 32.4% B 
cetu~cepacia B (n l l ), 2.9% B vietnamensis (n 1) and 5.9% B ambifaria (n 2).We 
found no differences in genotype, age, gender, sputum microbiology (other than 
BCC), CF related co morbidities, lung function or BMI  between genomovar III mad 
non III colonisation. Nine of 32 patients howed transient identification. Fitteen of 
16 genomovar I l l  and six of 14 non III genomovar BCC had persistent infection 
(Z9~4.9, p ~).C~)4). Rate of change in lung function (FEV1% predicted/year) were 
not different between cbronic and transient BCC prior to or after identification of 
BCC for genomovar III mad non IIL Conclusion: Transient identification of non4I I  
genomovar BCC occurs in adult CF patients. The rate of change in lung function 
was no different between persistent and transient BCC infection. 
Supported by TPCH Foutulation. 
136 
Staphylococcus aureus small colony variants in patients with cystic 
fibrosis in Franfur t/Main, Germany 
S. Besier 1, C. Smac~ay 2, C. van Mall incl~odt 2, H. G. Posselt ~, V. Brade 1, T.A. 
Wichelhans 1 
~Institute of Medical Microbiology, 2Departement of PuImology wM AIIergology, 
InteraaI Medicine, 3Departement of Pediatrics, University Hospital of Frankfurt/ 
Mabg Germany 
Aims The colonization of the respiratory tract by Staphylococcus aureus is a 
frequent feature of patients with cystic fibrosis (CF). It is asmmed that this 
pathogen can survive intr acellular ly and cause recurrent infections by the formation 
of a specific subpopulation the small colony variants (SCVs). A im of the present 
study was to determine the prevalence of S. aureus SCVs ha CF patients. 
Methods Sputa and deep flaroat swabs of CF patients attending the ambulances of 
the university hospital in Franld'urt/Main, Germany, between 01.01.2004 and 
31.12.2CO4 were screened for the presence of S. aureus SCVs. 
Results Of  267 patients, 120 (45%) harbored S. aureus ha their respiratory tract. Of  
these 120, 1C~) (83%) had normal S. aureus (NCVs) and 20 (17%) had NCVs plus 
SCVs or SCVs alone. The median age of patients with SCVs differed distinctly 
from the median ge of patients with only NCVs (30 years [range, 3 61; SEM, + 13] 
vs. 20 years [range, 1 46; SEM +11]). Persistence of the SCVs could be 
demonstrated for 50% (n 10) of SCVposit ive patients. A l l  SCV isolates were 
resistant o trimethoprim sulfamethoxazol (SXT) and high resistance rates were 
also dccumented for gentamicin (46%), erytbromycin (41%) and ciprofloxacin 
(29%). Prel iminary data indicate a correlation between SXT prophylaxis/ therapy 
and isolation of SCVs. 
Conclusions The presented ata show that S. aureus SCVs can be isolated 
frequently and repeatedly from the airways of CF patients. Further investigations 
are required to i l luminate the genetic background and pathogenic role of this S. 
aureus phenotype in persistent lung infections. 
